THE FREQUENCY AND PROGNOSTIC OF EZH2 MUTATIONS IN PATIENTS WITH BCR-ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

L. Polushkina, I. Martynkevich, E. Petrova, L. Martynenko, N. Cybakova, M. Petrova, E. Shabanova, I. Zotova, T. Zamotina, M. Fominykh, V. Shuvaev, K. Abdulkadyrov

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)660-660
Number of pages1
JournalHaematologica
Volume99
StatePublished - 1 Jun 2014
Event19th Congress of the European-Hematology-Association - Milan, Italy
Duration: 12 Jun 201415 Jun 2014

Cite this